{"schema_version":"secwatch.filing_event.v1","accession":"0000929638-24-000084","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.821482+00:00","generated_at":"2026-06-07T00:38:22.533295+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SeaStar Medical appoints David Green as CFO effective Jan 10, 2024","bullets":["David Green, 61, appointed CFO; previously CFO at BlackSwan Vascular and LamaMed Solutions.","Annual base salary of $375,000; eligible for annual bonus up to 40% of base salary.","Grant of 450,000 RSUs vesting 25% on first anniversary, remainder monthly over 36 months.","Caryl Baron, former Interim CFO, transitions to VP of Finance effective Jan 10, 2024.","Green brings 25+ years healthcare finance experience; also served as Interim CFO of Prolacta Bioscience."],"urls":{"canonical":"https://secwatch.observer/filing/0000929638-24-000084","json":"https://secwatch.observer/filing/0000929638-24-000084.json","markdown":"https://secwatch.observer/filing/0000929638-24-000084.md","text":"https://secwatch.observer/filing/0000929638-24-000084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/0000929638-24-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/a8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:38:22.533295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"21a4d6a2db","claim":"Caryl Baron changed role as Vice President of Finance at SeaStar Medical Holding Corp.","evidence_excerpt":"Also effective on January 10, 2024, Caryl Baron, who served as the Interim Chief Financial Officer of the Company since October 2022, will transition into the role of Vice President of Finance of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/0000929638-24-000084-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned into the role of"},{"label":"Role","value":"Vice President of Finance"}],"fact_type":"executive_change"},{"claim_id":"c7ff392191","claim":"David Green was appointed as Chief Financial Officer at SeaStar Medical Holding Corp.","evidence_excerpt":"On January 10, 2024, the Board of Directors (the “Board”) of SeaStar Medical Holding Corporation (the “Company”) appointed David Green, age 61, as the Company’s Chief Financial Officer, effective as of January 10, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/0000929638-24-000084-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}